首页> 美国卫生研究院文献>Brazilian Journal of Medical and Biological Research >Vancomycin-resistant enterococcus outbreak in a pediatric intensive care unit: report of successful interventions for control and prevention
【2h】

Vancomycin-resistant enterococcus outbreak in a pediatric intensive care unit: report of successful interventions for control and prevention

机译:儿科重症监护室中耐万古霉素的肠球菌暴发:成功控制和预防干预措施的报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The objective of this study is to retrospectively report the results of interventions for controlling a vancomycin-resistant enterococcus (VRE) outbreak in a tertiary-care pediatric intensive care unit (PICU) of a University Hospital. After identification of the outbreak, interventions were made at the following levels: patient care, microbiological surveillance, and medical and nursing staff training. Data were collected from computer-based databases and from the electronic prescription system. Vancomycin use progressively increased after March 2008, peaking in August 2009. Five cases of VRE infection were identified, with 3 deaths. After the interventions, we noted a significant reduction in vancomycin prescription and use (75% reduction), and the last case of VRE infection was identified 4 months later. The survivors remained colonized until hospital discharge. After interventions there was a transient increase in PICU length-of-stay and mortality. Since then, the use of vancomycin has remained relatively constant and strict, no other cases of VRE infection or colonization have been identified and length-of-stay and mortality returned to baseline. In conclusion, we showed that a bundle intervention aiming at a strict control of vancomycin use and full compliance with the Hospital Infection Control Practices Advisory Committee guidelines, along with contact precautions and hand-hygiene promotion, can be effective in reducing vancomycin use and the emergence and spread of vancomycin-resistant bacteria in a tertiary-care PICU.
机译:这项研究的目的是回顾性报告在大学医院的三级儿科重症监护病房(PICU)中控制耐万古霉素肠球菌(VRE)的干预措施的结果。在确定爆发之后,在以下级别进行干预:患者护理,微生物监测以及医护人员培训。从基于计算机的数据库和电子处方系统收集数据。 2008年3月后,万古霉素的使用量逐渐增加,到2009年8月达到峰值。确定了5例VRE感染病例,其中3例死亡。干预后,我们注意到万古霉素的处方和使用量显着减少(减少了75%),最后一个VRE感染病例是在4个月后确定的。幸存者一直定居直到出院。干预后,PICU的住院时间和死亡率都有短暂的增加。从那时起,万古霉素的使用一直保持相对稳定和严格,没有发现其他VRE感染或定植的病例,住院时间和死亡率均恢复到基线水平。总之,我们表明,旨在严格控制万古霉素使用并完全符合医院感染控制实践咨询委员会准则的捆绑干预措施,以及接触预防措施和手部卫生促进措施,可以有效减少万古霉素的使用和出现并在三级护理PICU中传播耐万古霉素的细菌。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号